TELA Bio, Inc. provided revenue guidance for the year 2024. For the year, the company expects Increased full year 2024 revenue guidance to $74.5 million to $76.5 million, representing 27% to 31% year-over-year growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.38 USD | +0.69% |
|
-6.81% | -33.84% |
Jul. 01 | TELA Bio, Inc.(NasdaqGM:TELA) dropped from Russell 3000E Growth Index | CI |
Jul. 01 | TELA Bio, Inc.(NasdaqGM:TELA) dropped from Russell 2000 Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.84% | 108M | |
-5.50% | 181B | |
-5.79% | 99.52B | |
-6.59% | 65.82B | |
-8.38% | 45.21B | |
+8.42% | 43.85B | |
+10.10% | 42.17B | |
+10.97% | 28.75B | |
+18.89% | 25.39B | |
-8.39% | 23.5B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio, Inc. Provides Revenue Guidance for the Year 2024